ID   HNRPC_HUMAN             Reviewed;         306 AA.
AC   P07910; D3DS19; D3DS22; P22628; Q53EX2; Q59FD3; Q5FWE8; Q86SF8; Q86U45;
AC   Q96HK7; Q96HM4; Q96IY5; Q9BTS3;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 4.
DT   07-APR-2021, entry version 248.
DE   RecName: Full=Heterogeneous nuclear ribonucleoproteins C1/C2;
DE            Short=hnRNP C1/C2;
GN   Name=HNRNPC; Synonyms=HNRPC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C2).
RX   PubMed=2557628; DOI=10.1073/pnas.86.24.9788;
RA   Burd C.G., Swanson M.S., Goerlach M., Dreyfuss G.;
RT   "Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1,
RT   and C2 proteins: a diversity of RNA binding proteins is generated by small
RT   peptide inserts.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:9788-9792(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C1).
RX   PubMed=3110598; DOI=10.1128/mcb.7.5.1731;
RA   Swanson M.S., Nakagawa T.Y., Levan K., Dreyfuss G.;
RT   "Primary structure of human nuclear ribonucleoprotein particle C proteins:
RT   conservation of sequence and domain structures in heterogeneous nuclear
RT   RNA, mRNA, and pre-rRNA-binding proteins.";
RL   Mol. Cell. Biol. 7:1731-1739(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS C1 AND 3).
RC   TISSUE=Neuroblastoma, and Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS C1; C2 AND 4).
RC   TISSUE=Bone marrow, Brain, Chondrosarcoma, Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-12; 18-39; 43-61; 74-89; 143-151; 188-198 AND
RP   205-216, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, and Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Cooper W.N., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 18-39; 51-61; 74-89 AND 207-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, ALTERNATIVE SPLICING, AND CHARACTERIZATION.
RX   PubMed=2587210; DOI=10.1093/nar/17.21.8441;
RA   Merrill B.M., Barnett S.F., Lestourgeon W.M., Williams K.R.;
RT   "Primary structure differences between proteins C1 and C2 of HeLa 40S
RT   nuclear ribonucleoprotein particles.";
RL   Nucleic Acids Res. 17:8441-8449(1989).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=8264621; DOI=10.1128/mcb.14.1.518;
RA   Huang M., Rech J.E., Northington S.J., Flicker P.F., Mayeda A.,
RA   Krainer A.R., LeStourgeon W.M.;
RT   "The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and
RT   nucleates the assembly of 40S heterogeneous nuclear ribonucleoprotein
RT   particles.";
RL   Mol. Cell. Biol. 14:518-533(1994).
RN   [11]
RP   FUNCTION.
RX   PubMed=7567451; DOI=10.1093/nar/23.17.3419;
RA   Sebillon P., Beldjord C., Kaplan J.-C., Brody E., Marie J.;
RT   "A T to G mutation in the polypyrimidine tract of the second intron of the
RT   human beta-globin gene reduces in vitro splicing efficiency: evidence for
RT   an increased hnRNP C interaction.";
RL   Nucleic Acids Res. 23:3419-3425(1995).
RN   [12]
RP   INTERACTION WITH DHX9.
RX   PubMed=11687588; DOI=10.1074/jbc.m109393200;
RA   Zhang S., Buder K., Burkhardt C., Schlott B., Goerlach M., Grosse F.;
RT   "Nuclear DNA helicase II/RNA helicase A binds to filamentous actin.";
RL   J. Biol. Chem. 277:843-853(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [14]
RP   PHOSPHORYLATION AT SER-253; SER-260 AND SER-299, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12564933; DOI=10.1021/bi0268091;
RA   Stone J.R., Maki J.L., Collins T.;
RT   "Basal and hydrogen peroxide stimulated sites of phosphorylation in
RT   heterogeneous nuclear ribonucleoprotein C1/C2.";
RL   Biochemistry 42:1301-1308(2003).
RN   [15]
RP   FUNCTION.
RX   PubMed=12509468; DOI=10.1128/mcb.23.2.708-720.2003;
RA   Kim J.H., Paek K.Y., Choi K., Kim T.-D., Hahm B., Kim K.-T., Jang S.K.;
RT   "Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc
RT   mRNA in a cell cycle phase-dependent manner.";
RL   Mol. Cell. Biol. 23:708-720(2003).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [17]
RP   MUTAGENESIS OF LYS-197 AND LYS-250, AND SUMOYLATION AT LYS-250.
RX   PubMed=15082759; DOI=10.1128/mcb.24.9.3623-3632.2004;
RA   Vassileva M.T., Matunis M.J.;
RT   "SUMO modification of heterogeneous nuclear ribonucleoproteins.";
RL   Mol. Cell. Biol. 24:3623-3632(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=16010978; DOI=10.1007/s11010-005-7644-2;
RA   Shetty S.;
RT   "Regulation of urokinase receptor mRNA stability by hnRNP C in lung
RT   epithelial cells.";
RL   Mol. Cell. Biochem. 272:107-118(2005).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162; SER-233; SER-253 AND
RP   SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.m700120-mcp200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J.,
RA   Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate reductase
RT   M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal
RT   transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [22]
RP   INTERACTION WITH IGF2BP1.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253 AND SER-260, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-233; SER-241 AND
RP   SER-299, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107 AND SER-108
RP   (ISOFORMS 4 AND C1), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-253; SER-260;
RP   SER-299 AND SER-306, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-109; SER-113; SER-115;
RP   SER-233; SER-253 AND SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-260 AND SER-299, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166; SER-233; SER-241;
RP   SER-253; SER-260; SER-299 AND SER-306, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-107 (ISOFORMS 4 AND C1), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-238; SER-241;
RP   SER-253 AND SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115; SER-233; SER-238;
RP   SER-239; SER-253 AND SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-89; LYS-176; LYS-229;
RP   LYS-232 AND LYS-243, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-229 AND LYS-232, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [37]
RP   INTERACTION WITH PPIA.
RX   PubMed=25678563; DOI=10.1093/brain/awv005;
RA   Lauranzano E., Pozzi S., Pasetto L., Stucchi R., Massignan T., Paolella K.,
RA   Mombrini M., Nardo G., Lunetta C., Corbo M., Mora G., Bendotti C.,
RA   Bonetto V.;
RT   "Peptidylprolyl isomerase A governs TARDBP function and assembly in
RT   heterogeneous nuclear ribonucleoprotein complexes.";
RL   Brain 138:974-991(2015).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-94; LYS-229; LYS-232;
RP   LYS-243 AND LYS-244, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-176; LYS-223; LYS-229;
RP   LYS-232; LYS-243 AND LYS-244, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [40]
RP   FUNCTION, AND RNA-BINDING.
RX   PubMed=25719671; DOI=10.1038/nature14234;
RA   Liu N., Dai Q., Zheng G., He C., Parisien M., Pan T.;
RT   "N(6)-methyladenosine-dependent RNA structural switches regulate RNA-
RT   protein interactions.";
RL   Nature 518:560-564(2015).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-50; LYS-89; LYS-176;
RP   LYS-223; LYS-229; LYS-232; LYS-243 AND LYS-250, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [43]
RP   STRUCTURE BY NMR OF 1-94.
RX   PubMed=1385725; DOI=10.1021/bi00142a013;
RA   Witteking M., Goerlach M., Friedrichs M., Dreyfuss G., Mueller L.;
RT   "1H, 13C, and 15N NMR assignments and global folding pattern of the RNA-
RT   binding domain of the human hnRNP C proteins.";
RL   Biochemistry 31:6254-6265(1992).
RN   [44]
RP   STRUCTURE BY NMR OF 1-94.
RX   PubMed=1380452; DOI=10.1002/j.1460-2075.1992.tb05407.x;
RA   Goerlach M., Witteking M., Beckman R.A., Mueller L., Dreyfuss G.;
RT   "Interaction of the RNA-binding domain of the hnRNP C proteins with RNA.";
RL   EMBO J. 11:3289-3295(1992).
RN   [45]
RP   STRUCTURE BY NMR OF 193-220, AND SUBUNIT.
RX   PubMed=11162094; DOI=10.1006/jmbi.2000.4331;
RA   Shahied L., Braswell E.H., LeStourgeon W.M., Krezel A.M.;
RT   "An antiparallel four-helix bundle orients the high-affinity RNA binding
RT   sites in hnRNP C: a mechanism for RNA chaperonin activity.";
RL   J. Mol. Biol. 305:817-828(2001).
RN   [46]
RP   STRUCTURE BY NMR OF 8-92.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RRM domain in HNRPC protein.";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [47]
RP   STRUCTURE BY NMR OF 193-220, AND SUBUNIT.
RX   PubMed=15936032; DOI=10.1016/j.jmb.2005.05.002;
RA   Whitson S.R., LeStourgeon W.M., Krezel A.M.;
RT   "Solution structure of the symmetric coiled coil tetramer formed by the
RT   oligomerization domain of hnRNP C: implications for biological function.";
RL   J. Mol. Biol. 350:319-337(2005).
CC   -!- FUNCTION: Binds pre-mRNA and nucleates the assembly of 40S hnRNP
CC       particles (PubMed:8264621). Interacts with poly-U tracts in the 3'-UTR
CC       or 5'-UTR of mRNA and modulates the stability and the level of
CC       translation of bound mRNA molecules (PubMed:12509468, PubMed:16010978,
CC       PubMed:7567451, PubMed:8264621). Single HNRNPC tetramers bind 230-240
CC       nucleotides. Trimers of HNRNPC tetramers bind 700 nucleotides
CC       (PubMed:8264621). May play a role in the early steps of spliceosome
CC       assembly and pre-mRNA splicing. N6-methyladenosine (m6A) has been shown
CC       to alter the local structure in mRNAs and long non-coding RNAs
CC       (lncRNAs) via a mechanism named 'm(6)A-switch', facilitating binding of
CC       HNRNPC, leading to regulation of mRNA splicing (PubMed:25719671).
CC       {ECO:0000269|PubMed:12509468, ECO:0000269|PubMed:16010978,
CC       ECO:0000269|PubMed:25719671, ECO:0000269|PubMed:7567451,
CC       ECO:0000269|PubMed:8264621}.
CC   -!- SUBUNIT: Tetramer composed of 3 copies of isoform C1 and 1 copy of
CC       isoform C2. Assembly of 3 tetramers with bound pre-mRNA gives rise to a
CC       19S complex that interacts with HNRNPA2B1 tetramers. Component of the
CC       40S hnRNP particle. Identified in the spliceosome C complex. Interacts
CC       with IGF2BP1. Interacts with DHX9; this interaction is direct, enhanced
CC       probably by their concomitant binding to RNA and mediates the
CC       attachment to actin filaments (PubMed:11687588). Interacts with
CC       PPIA/CYPA (PubMed:25678563). {ECO:0000269|PubMed:11162094,
CC       ECO:0000269|PubMed:11687588, ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:15936032, ECO:0000269|PubMed:17289661,
CC       ECO:0000269|PubMed:25678563, ECO:0000269|PubMed:8264621}.
CC   -!- INTERACTION:
CC       P07910; Q99459: CDC5L; NbExp=2; IntAct=EBI-357966, EBI-374880;
CC       P07910; Q9NR30: DDX21; NbExp=3; IntAct=EBI-357966, EBI-357942;
CC       P07910; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-357966, EBI-11988027;
CC       P07910; Q12929: EPS8; NbExp=3; IntAct=EBI-357966, EBI-375576;
CC       P07910; P09651: HNRNPA1; NbExp=3; IntAct=EBI-357966, EBI-352662;
CC       P07910; P07910: HNRNPC; NbExp=8; IntAct=EBI-357966, EBI-357966;
CC       P07910; O60812: HNRNPCL1; NbExp=3; IntAct=EBI-357966, EBI-1046507;
CC       P07910; B2RXH8: HNRNPCL2; NbExp=3; IntAct=EBI-357966, EBI-9512317;
CC       P07910; P42858: HTT; NbExp=7; IntAct=EBI-357966, EBI-466029;
CC       P07910; Q9NQR1: KMT5A; NbExp=2; IntAct=EBI-357966, EBI-1268946;
CC       P07910; P52292: KPNA2; NbExp=4; IntAct=EBI-357966, EBI-349938;
CC       P07910; O00505: KPNA3; NbExp=5; IntAct=EBI-357966, EBI-358297;
CC       P07910; O00629: KPNA4; NbExp=6; IntAct=EBI-357966, EBI-396343;
CC       P07910; P25791: LMO2; NbExp=3; IntAct=EBI-357966, EBI-739696;
CC       P07910; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-357966, EBI-16439278;
CC       P07910; P26367: PAX6; NbExp=3; IntAct=EBI-357966, EBI-747278;
CC       P07910; Q53GL6: RALY; NbExp=3; IntAct=EBI-357966, EBI-9512693;
CC       P07910; Q9UKM9: RALY; NbExp=2; IntAct=EBI-357966, EBI-714796;
CC       P07910; Q86SE5: RALYL; NbExp=7; IntAct=EBI-357966, EBI-741520;
CC       P07910; Q86SE5-3: RALYL; NbExp=3; IntAct=EBI-357966, EBI-11526555;
CC       P07910; Q96IZ5: RBM41; NbExp=5; IntAct=EBI-357966, EBI-740773;
CC       P07910; Q6ZRY4: RBPMS2; NbExp=3; IntAct=EBI-357966, EBI-11987469;
CC       P07910; P78317: RNF4; NbExp=3; IntAct=EBI-357966, EBI-2340927;
CC       P07910; O00560: SDCBP; NbExp=6; IntAct=EBI-357966, EBI-727004;
CC       P07910; Q9BYB0: SHANK3; NbExp=2; IntAct=EBI-357966, EBI-1752330;
CC       P07910; P78362: SRPK2; NbExp=2; IntAct=EBI-357966, EBI-593303;
CC       P07910; P63165: SUMO1; NbExp=6; IntAct=EBI-357966, EBI-80140;
CC       P07910; G2XKQ0: SUMO1P1; NbExp=3; IntAct=EBI-357966, EBI-10175576;
CC       P07910; Q13148: TARDBP; NbExp=3; IntAct=EBI-357966, EBI-372899;
CC       P07910; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-357966, EBI-10180829;
CC       P07910; P63104: YWHAZ; NbExp=2; IntAct=EBI-357966, EBI-347088;
CC       P07910; Q68DK2-5: ZFYVE26; NbExp=3; IntAct=EBI-357966, EBI-8656416;
CC       P07910-2; P42858: HTT; NbExp=9; IntAct=EBI-5280084, EBI-466029;
CC       P07910-2; Q13148: TARDBP; NbExp=6; IntAct=EBI-5280084, EBI-372899;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Component of ribonucleosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=C2;
CC         IsoId=P07910-1; Sequence=Displayed;
CC       Name=C1;
CC         IsoId=P07910-2; Sequence=VSP_005831;
CC       Name=3;
CC         IsoId=P07910-3; Sequence=VSP_019225;
CC       Name=4;
CC         IsoId=P07910-4; Sequence=VSP_005831, VSP_019226;
CC   -!- PTM: Phosphorylated on Ser-260 and Ser-299 in resting cells.
CC       Phosphorylated on Ser-253 and on 1 serine residue in the poly-Ser
CC       stretch at position 238 in response to hydrogen peroxide.
CC       {ECO:0000269|PubMed:12564933}.
CC   -!- PTM: Sumoylated. Sumoylation reduces affinity for mRNA.
CC       {ECO:0000269|PubMed:15082759}.
CC   -!- SIMILARITY: Belongs to the RRM HNRPC family. RALY subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92764.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M29063; AAA36576.1; -; mRNA.
DR   EMBL; M16342; AAA52680.1; -; mRNA.
DR   EMBL; BX161480; CAD61934.1; -; mRNA.
DR   EMBL; BX247961; CAD62300.1; -; mRNA.
DR   EMBL; BX247992; CAD62326.1; -; mRNA.
DR   EMBL; AB209527; BAD92764.1; ALT_INIT; mRNA.
DR   EMBL; AK223517; BAD97237.1; -; mRNA.
DR   EMBL; CH471078; EAW66392.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66393.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66394.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66395.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66396.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66399.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66400.1; -; Genomic_DNA.
DR   EMBL; BC003394; AAH03394.1; -; mRNA.
DR   EMBL; BC007052; AAH07052.1; -; mRNA.
DR   EMBL; BC008364; AAH08364.1; -; mRNA.
DR   EMBL; BC008423; AAH08423.1; -; mRNA.
DR   EMBL; BC066932; AAH66932.1; -; mRNA.
DR   EMBL; BC089438; AAH89438.1; -; mRNA.
DR   EMBL; BC108658; AAI08659.1; -; mRNA.
DR   EMBL; BC103758; AAI03759.1; -; mRNA.
DR   CCDS; CCDS41915.1; -. [P07910-1]
DR   CCDS; CCDS45079.1; -. [P07910-2]
DR   PIR; A26885; A26885.
DR   PIR; C34504; C34504.
DR   RefSeq; NP_001070910.1; NM_001077442.1. [P07910-1]
DR   RefSeq; NP_001070911.1; NM_001077443.1. [P07910-2]
DR   RefSeq; NP_004491.2; NM_004500.3. [P07910-2]
DR   RefSeq; NP_112604.2; NM_031314.2. [P07910-1]
DR   RefSeq; XP_006720188.1; XM_006720125.2. [P07910-2]
DR   RefSeq; XP_011535010.1; XM_011536708.1. [P07910-1]
DR   RefSeq; XP_011535011.1; XM_011536709.2. [P07910-1]
DR   RefSeq; XP_011535012.1; XM_011536710.2. [P07910-1]
DR   RefSeq; XP_011535013.1; XM_011536711.2. [P07910-1]
DR   RefSeq; XP_011535014.1; XM_011536712.1. [P07910-2]
DR   RefSeq; XP_016876741.1; XM_017021252.1. [P07910-2]
DR   RefSeq; XP_016876742.1; XM_017021253.1. [P07910-2]
DR   PDB; 1TXP; NMR; -; A/B/C/D=194-220.
DR   PDB; 1WF2; NMR; -; A=8-92.
DR   PDB; 2MXY; NMR; -; A=2-106.
DR   PDB; 2MZ1; NMR; -; A=2-106.
DR   PDB; 3LN4; X-ray; 1.30 A; C=102-117.
DR   PDBsum; 1TXP; -.
DR   PDBsum; 1WF2; -.
DR   PDBsum; 2MXY; -.
DR   PDBsum; 2MZ1; -.
DR   PDBsum; 3LN4; -.
DR   BMRB; P07910; -.
DR   SMR; P07910; -.
DR   BioGRID; 109424; 338.
DR   CORUM; P07910; -.
DR   DIP; DIP-29854N; -.
DR   IntAct; P07910; 196.
DR   MINT; P07910; -.
DR   STRING; 9606.ENSP00000451291; -.
DR   ChEMBL; CHEMBL2216742; -.
DR   iPTMnet; P07910; -.
DR   MetOSite; P07910; -.
DR   PhosphoSitePlus; P07910; -.
DR   SwissPalm; P07910; -.
DR   BioMuta; HNRNPC; -.
DR   DMDM; 108935845; -.
DR   SWISS-2DPAGE; P07910; -.
DR   EPD; P07910; -.
DR   jPOST; P07910; -.
DR   MassIVE; P07910; -.
DR   MaxQB; P07910; -.
DR   PaxDb; P07910; -.
DR   PeptideAtlas; P07910; -.
DR   PRIDE; P07910; -.
DR   ProteomicsDB; 52034; -. [P07910-1]
DR   ProteomicsDB; 52035; -. [P07910-2]
DR   ProteomicsDB; 52036; -. [P07910-3]
DR   ProteomicsDB; 52037; -. [P07910-4]
DR   TopDownProteomics; P07910-1; -. [P07910-1]
DR   TopDownProteomics; P07910-2; -. [P07910-2]
DR   Antibodypedia; 3927; 470 antibodies.
DR   DNASU; 3183; -.
DR   Ensembl; ENST00000420743; ENSP00000404848; ENSG00000092199. [P07910-1]
DR   Ensembl; ENST00000430246; ENSP00000442816; ENSG00000092199. [P07910-2]
DR   Ensembl; ENST00000553300; ENSP00000450544; ENSG00000092199. [P07910-2]
DR   Ensembl; ENST00000554455; ENSP00000451291; ENSG00000092199. [P07910-1]
DR   Ensembl; ENST00000554969; ENSP00000450725; ENSG00000092199. [P07910-2]
DR   Ensembl; ENST00000555883; ENSP00000450629; ENSG00000092199. [P07910-4]
DR   Ensembl; ENST00000556628; ENSP00000451652; ENSG00000092199. [P07910-3]
DR   Ensembl; ENST00000556897; ENSP00000451176; ENSG00000092199. [P07910-2]
DR   Ensembl; ENST00000557201; ENSP00000452276; ENSG00000092199. [P07910-1]
DR   GeneID; 3183; -.
DR   KEGG; hsa:3183; -.
DR   UCSC; uc001vzw.5; human. [P07910-1]
DR   CTD; 3183; -.
DR   DisGeNET; 3183; -.
DR   GeneCards; HNRNPC; -.
DR   HGNC; HGNC:5035; HNRNPC.
DR   HPA; ENSG00000092199; Low tissue specificity.
DR   MIM; 164020; gene.
DR   neXtProt; NX_P07910; -.
DR   OpenTargets; ENSG00000092199; -.
DR   PharmGKB; PA162391217; -.
DR   VEuPathDB; HostDB:ENSG00000092199.17; -.
DR   eggNOG; KOG0118; Eukaryota.
DR   GeneTree; ENSGT00940000153402; -.
DR   InParanoid; P07910; -.
DR   OMA; RPAGDMY; -.
DR   OrthoDB; 1211602at2759; -.
DR   PhylomeDB; P07910; -.
DR   TreeFam; TF330974; -.
DR   PathwayCommons; P07910; -.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   SIGNOR; P07910; -.
DR   BioGRID-ORCS; 3183; 721 hits in 943 CRISPR screens.
DR   ChiTaRS; HNRNPC; human.
DR   EvolutionaryTrace; P07910; -.
DR   GeneWiki; HNRNPC; -.
DR   GenomeRNAi; 3183; -.
DR   Pharos; P07910; Tbio.
DR   PRO; PR:P07910; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P07910; protein.
DR   Bgee; ENSG00000092199; Expressed in testis and 214 other tissues.
DR   ExpressionAtlas; P07910; baseline and differential.
DR   Genevisible; P07910; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0000785; C:chromatin; HDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IDA:HGNC-UCL.
DR   GO; GO:0005697; C:telomerase holoenzyme complex; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:1990247; F:N6-methyladenosine-containing RNA binding; IDA:UniProtKB.
DR   GO; GO:0031492; F:nucleosomal DNA binding; HDA:UniProtKB.
DR   GO; GO:0008266; F:poly(U) RNA binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IPI:BHF-UCL.
DR   GO; GO:0070034; F:telomerase RNA binding; IPI:BHF-UCL.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; IMP:UniProtKB.
DR   GO; GO:0043044; P:ATP-dependent chromatin remodeling; HDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0016070; P:RNA metabolic process; TAS:Reactome.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR017347; hnRNP_C.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 1.
DR   PIRSF; PIRSF037992; hnRNP-C_Raly; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil;
KW   Direct protein sequencing; Isopeptide bond; mRNA processing; mRNA splicing;
KW   Nucleus; Phosphoprotein; Reference proteome; Ribonucleoprotein;
KW   RNA-binding; Spliceosome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.7, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..306
FT                   /note="Heterogeneous nuclear ribonucleoproteins C1/C2"
FT                   /id="PRO_0000081844"
FT   DOMAIN          16..87
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   COILED          190..238
FT                   /evidence="ECO:0000255"
FT   MOTIF           155..161
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        181..303
FT                   /note="Asp/Glu-rich (acidic)"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.7, ECO:0007744|PubMed:22814378"
FT   MOD_RES         109
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         121
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z204"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         176
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z204"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         241
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12564933,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12564933,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:17693683,
FT                   ECO:0007744|PubMed:18318008, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12564933,
FT                   ECO:0007744|PubMed:16807684, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:19367720,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:21406692"
FT   CROSSLNK        8
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        50
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        89
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        94
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25772364"
FT   CROSSLNK        176
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:28112733"
FT   CROSSLNK        223
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        229
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733"
FT   CROSSLNK        232
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        232
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        243
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        244
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:25772364"
FT   CROSSLNK        250
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT   CROSSLNK        250
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         39..119
FT                   /note="KYGKIVGCSVHKGFAFVQYVNERNARAAVAGEDGRMIAGQVLDINLAAEPKV
FT                   NRGKAGVKRSAAEMYGSVTEHPSPSPLLS -> N (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_019225"
FT   VAR_SEQ         108..120
FT                   /note="Missing (in isoform C1 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3110598, ECO:0000303|Ref.3"
FT                   /id="VSP_005831"
FT   VAR_SEQ         153..195
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_019226"
FT   MUTAGEN         197
FT                   /note="K->R: No effect on sumoylation."
FT                   /evidence="ECO:0000269|PubMed:15082759"
FT   MUTAGEN         250
FT                   /note="K->R: Loss of sumoylation."
FT                   /evidence="ECO:0000269|PubMed:15082759"
FT   CONFLICT        110
FT                   /note="E -> G (in Ref. 6; AAH08423)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        217
FT                   /note="I -> M (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        224
FT                   /note="Q -> R (in Ref. 6; AAH08364)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="K -> R (in Ref. 6; AAH08364)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254
FT                   /note="E -> G (in Ref. 6; AAH07052)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        303..306
FT                   /note="EDDS -> G (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   TURN            11..13
FT                   /evidence="ECO:0007744|PDB:2MXY"
FT   STRAND          18..23
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   TURN            25..27
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   HELIX           30..35
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   TURN            38..40
FT                   /evidence="ECO:0007744|PDB:2MZ1"
FT   STRAND          43..49
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   STRAND          51..59
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   HELIX           60..68
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   TURN            69..72
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   STRAND          81..84
FT                   /evidence="ECO:0007744|PDB:1WF2"
FT   STRAND          94..96
FT                   /evidence="ECO:0007744|PDB:2MXY"
FT   HELIX           194..216
FT                   /evidence="ECO:0007744|PDB:1TXP"
FT   MOD_RES         P07910-2:107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         P07910-2:108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         P07910-4:107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         P07910-4:108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
SQ   SEQUENCE   306 AA;  33670 MW;  17BBC78690C69C5C CRC64;
     MASNVTNKTD PRSMNSRVFI GNLNTLVVKK SDVEAIFSKY GKIVGCSVHK GFAFVQYVNE
     RNARAAVAGE DGRMIAGQVL DINLAAEPKV NRGKAGVKRS AAEMYGSVTE HPSPSPLLSS
     SFDLDYDFQR DYYDRMYSYP ARVPPPPPIA RAVVPSKRQR VSGNTSRRGK SGFNSKSGQR
     GSSKSGKLKG DDLQAIKKEL TQIKQKVDSL LENLEKIEKE QSKQAVEMKN DKSEEEQSSS
     SVKKDETNVK MESEGGADDS AEEGDLLDDD DNEDRGDDQL ELIKDDEKEA EEGEDDRDSA
     NGEDDS
//
